Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-19-023467
Filing Date
2019-11-14
Accepted
2019-11-14 16:05:25
Documents
63
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0919_chinapharmaholding.htm 10-Q 357701
2 CERTIFICATION f10q0919ex31-1_chinapharma.htm EX-31.1 8750
3 CERTIFICATION f10q0919ex31-2_chinapharma.htm EX-31.2 8962
4 CERTIFICATION f10q0919ex32-1_chinapharma.htm EX-32.1 5641
  Complete submission text file 0001213900-19-023467.txt   2406885

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE cphi-20190630.xml EX-101.INS 322439
6 XBRL SCHEMA FILE cphi-20190630.xsd EX-101.SCH 34771
7 XBRL CALCULATION FILE cphi-20190630_cal.xml EX-101.CAL 59267
8 XBRL DEFINITION FILE cphi-20190630_def.xml EX-101.DEF 76812
9 XBRL LABEL FILE cphi-20190630_lab.xml EX-101.LAB 239542
10 XBRL PRESENTATION FILE cphi-20190630_pre.xml EX-101.PRE 182298
Mailing Address 2ND FLOOR, NO. 17, JINPAN ROAD HAIKOU HAINAN PROVINCE F4 570216
Business Address 2ND FLOOR, NO. 17, JINPAN ROAD HAIKOU HAINAN PROVINCE F4 570216 8689866811730
CHINA PHARMA HOLDINGS, INC. (Filer) CIK: 0001106644 (see all company filings)

EIN.: 731564807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34471 | Film No.: 191220004
SIC: 2834 Pharmaceutical Preparations